Group
|
Protein (μg/mg Tissue)
|
H2O2 (nM/min/mg Tissue)
|
Nitrite (NO) (content μM/ml)
|
MDA (nM/min/mg protein)
|
---|
Control
|
4.66 ± 0.05b
|
1.97 ± 0.06b
|
34.77 ± 1.32b
|
3.5 ± 0.156b
|
CP
|
1.19 ± 0.05a
|
5.39 ± 0.256a
|
90.41 ± 1.28a
|
8.97 ± 0.337a
|
AHE alone
|
4.67 ± 0.15b
|
1.32 ± 0.06b
|
36.24 ± 0.96b
|
3.153 ± 0.087 b
|
CP + AHE
|
3.25 ± 0.13a,b,d**
|
4.325 ± 0.198a,b**,d
|
71.48 ± 1.86a,b,d
|
6.11 ± 0.504a,b, d*
|
AHE + CP
|
3.92 ± 0.04a**,b, c**
|
2.38 ± 0.189b,c
|
41.09 ± 0.69a*,b,c
|
4.84 ± 0.06a*,b,c*
|
CP + Sily
|
3.93 ± 0.11a**,b
|
2.39 ± 0.037b
|
40.98 ± 1.38a*,b
|
4.90 ± 0.107a*,b
|
- Values expressed as mean ± SEM
-
a Significance at p < 0.0001 Vs. control group
-
b Significance at p < 0.0001 Vs. Cisplatin (CP) group
-
c Significance at p < 0.0001 of AHE + CP pre-treated group Vs. CP + AHE post-treated group
-
d Significance at p < 0.0001 of CP + AHE treatment groups Vs CP + Sily group
-
*,** Significant difference at p < 0.001. Non-significant difference (p > 0.05) was recorded between control and AHE alone treated group in all parameters (One way ANOVA followed by Tukey’s multiple comparison tests)